Literature DB >> 12819654

Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice.

R Ezzahiri1, F R M Stassen, H A J M Kurvers, M M L van Pul, P J E H M Kitslaar, C A Bruggeman.   

Abstract

OBJECTIVES: To study whether Chlamydia pneumoniae (Cpn) infection affects atherosclerotic plaque morphology in atherogenic (LDLr/ApoE(-/-)) mice.
METHODS: In mice sacrificed 20 or 40 weeks after Cpn infection aortic arch sections were analysed for lesion and fibrous cap area and the presence of matrix metalloproteinases (MMP)-2 and -9.
RESULTS: All infected mice seroconverted, demonstrated Cpn DNA in their aortas on PCR and developed atherosclerotic plaques. Infection was not associated with changes in lesion area or type, but was associated with reduced the fibrous cap area and increased MMP-2 and -9 immunoreactivity.
CONCLUSION: These findings suggest that Cpn infection may predispose to plaque instability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819654     DOI: 10.1053/ejvs.2002.1913

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  13 in total

Review 1.  Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.

Authors:  J Thomas Grayston; Robert J Belland; Gerald I Byrne; Cho Chou Kuo; Julius Schachter; Walter E Stamm; Guangming Zhong
Journal:  Pathog Dis       Date:  2014-12-04       Impact factor: 3.166

Review 2.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

3.  Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells.

Authors:  Lee Ann Campbell; Mirja Puolakkainen; Amy Lee; Michael E Rosenfeld; H Jacques Garrigues; Cho-Chou Kuo
Journal:  Microbes Infect       Date:  2011-08-30       Impact factor: 2.700

4.  The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis.

Authors:  Lee Ann Campbell; Kambiz Yaraei; Brian Van Lenten; Alan Chait; Erwin Blessing; Cho-Chou Kuo; Tadayoshi Nosaka; Jerry Ricks; Michael E Rosenfeld
Journal:  Microbes Infect       Date:  2010-04-22       Impact factor: 2.700

5.  Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis.

Authors:  Jürgen Rödel; Dirk Prochnau; Katrin Prager; Jürgen Baumert; Karl-Hermann Schmidt; Eberhard Straube
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Chlamydia pneumoniae Infection and Inflammatory Diseases.

Authors:  Rebecca A Porritt; Timothy R Crother
Journal:  For Immunopathol Dis Therap       Date:  2016

7.  Aspirin inhibits MMP-2 and MMP-9 expression and activity through PPARalpha/gamma and TIMP-1-mediated mechanisms in cultured mouse celiac macrophages.

Authors:  Yao Yiqin; Xie Meilin; Xue Jie; Zhang Keping
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

Review 8.  Thrombin generation and atherosclerosis.

Authors:  Jana Kalz; Hugo ten Cate; Henri M H Spronk
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

9.  Antibiotics for secondary prevention of coronary heart disease.

Authors:  Naqash J Sethi; Sanam Safi; Steven Kwasi Korang; Asbjørn Hróbjartsson; Maria Skoog; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-02-23

10.  Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune System.

Authors:  Chris Carter
Journal:  Int J Alzheimers Dis       Date:  2011-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.